A significant breakthrough in cancer study is emerging with the use of mini-antibodies to reactivate damaged p53. This essential malignant suppressor protein is frequently inactivated in various types of malignancies, https://bookmarkhard.com/story21984585/nanobodies-revive-the-p53-protein-new-potential-pathway-for-malignant-management